Bone Care International a Middleton-based University of Wisconsin spin-off announced Tuesday that it had received a new patent on stabilized hydroxyvitamin D that will extend protection of its core druc Hectorol. The patent which will expire in 2021 covers the company's hormone therapy treatment for hyperparathyroidism in chronic kidney disease patients as well as the new version